arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

download Export Data

MiniMed Group, Inc.

MMED

$19.64 ▲ +1.22 (+6.62%) at close

12 Visible periods

23 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

MiniMed Group, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth 15.6% ↗

Op. Margin -11.1% ↗

ROIC -5.2%

FCF / Share —

Trailing P/E —

Price / Book 1.5x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

12-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$837.00M

↑ +15.6% —

Net Income Profit after all expenses

$-185.00M

↓ -7.6% —

Operating Margin Operating profit as % of sales

-11.1%

↑ +12.2% 17th

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q4 FY2026 Apr 24, 2026 10-K ↗	Q3 FY2026 Jan 23, 2026 10-Q ↗	Q1 FY2026 Jan 23, 2026 10-Q ↗	Q4 FY2025 Apr 25, 2025 10-K ↗	Q3 FY2025 Oct 24, 2025 10-Q ↗	Q2 FY2025 Jul 25, 2025 10-Q ↗	Q1 FY2025 Apr 25, 2025 10-Q ↗	Q4 FY2024 Apr 26, 2024 10-K ↗	Q3 FY2024 Oct 25, 2024 10-Q ↗	Q2 FY2024 Jul 26, 2024 10-Q ↗	Q1 FY2024 Apr 26, 2024 10-Q ↗	Q4 FY2023 Apr 28, 2023 10-K ↗
Revenue Growth YoY (%)	15.6% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+95%)	15.0% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+87%)	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-4.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-1075.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-7.6% Weak Weak Year-over-year change in net income	-1090.0% Weak Weak Year-over-year change in net income	—	—	47.4% Excellent Excellent Year-over-year change in net income	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q4 FY2026 Apr 24, 2026 10-K ↗	Q3 FY2026 Jan 23, 2026 10-Q ↗	Q1 FY2026 Jan 23, 2026 10-Q ↗	Q4 FY2025 Apr 25, 2025 10-K ↗	Q3 FY2025 Oct 24, 2025 10-Q ↗	Q2 FY2025 Jul 25, 2025 10-Q ↗	Q1 FY2025 Apr 25, 2025 10-Q ↗	Q4 FY2024 Apr 26, 2024 10-K ↗	Q3 FY2024 Oct 25, 2024 10-Q ↗	Q2 FY2024 Jul 26, 2024 10-Q ↗	Q1 FY2024 Apr 26, 2024 10-Q ↗	Q4 FY2023 Apr 28, 2023 10-K ↗
Operating Margin (%) (%)	-11.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-174%)	-12.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-184%)	—	-20.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-236%)	3.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-80%)	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	-101.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-12.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	-14.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	133.3% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—
Profit Margin (%) (%)	-22.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-284%)	-15.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-226%)	—	-23.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-298%)	-1.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-112%)	—	—	—	—	—	—	—
FCF Margin (%) (%)	-27.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	3.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.22x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	-0.15x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q4 FY2026 Apr 24, 2026 10-K ↗	Q3 FY2026 Jan 23, 2026 10-Q ↗	Q1 FY2026 Jan 23, 2026 10-Q ↗	Q4 FY2025 Apr 25, 2025 10-K ↗	Q3 FY2025 Oct 24, 2025 10-Q ↗	Q2 FY2025 Jul 25, 2025 10-Q ↗	Q1 FY2025 Apr 25, 2025 10-Q ↗	Q4 FY2024 Apr 26, 2024 10-K ↗	Q3 FY2024 Oct 25, 2024 10-Q ↗	Q2 FY2024 Jul 26, 2024 10-Q ↗	Q1 FY2024 Apr 26, 2024 10-Q ↗	Q4 FY2023 Apr 28, 2023 10-K ↗
Return on Invested Capital (%)	-5.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	-5.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-0.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—
Return on Capital (%) (%)	-2.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-3.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-5.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	—	—	-5.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	-0.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-102%)	—	—	—	-0.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-104%)	—	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q4 FY2026 Apr 24, 2026 10-K ↗	Q3 FY2026 Jan 23, 2026 10-Q ↗	Q1 FY2026 Jan 23, 2026 10-Q ↗	Q4 FY2025 Apr 25, 2025 10-K ↗	Q3 FY2025 Oct 24, 2025 10-Q ↗	Q2 FY2025 Jul 25, 2025 10-Q ↗	Q1 FY2025 Apr 25, 2025 10-Q ↗	Q4 FY2024 Apr 26, 2024 10-K ↗	Q3 FY2024 Oct 25, 2024 10-Q ↗	Q2 FY2024 Jul 26, 2024 10-Q ↗	Q1 FY2024 Apr 26, 2024 10-Q ↗	Q4 FY2023 Apr 28, 2023 10-K ↗
Net Debt (USD)	$-298.00M	—	$-10.00M	$-11.00M	—	—	$-11.00M	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q4 FY2026 Apr 24, 2026 10-K ↗	Q3 FY2026 Jan 23, 2026 10-Q ↗	Q1 FY2026 Jan 23, 2026 10-Q ↗	Q4 FY2025 Apr 25, 2025 10-K ↗	Q3 FY2025 Oct 24, 2025 10-Q ↗	Q2 FY2025 Jul 25, 2025 10-Q ↗	Q1 FY2025 Apr 25, 2025 10-Q ↗	Q4 FY2024 Apr 26, 2024 10-K ↗	Q3 FY2024 Oct 25, 2024 10-Q ↗	Q2 FY2024 Jul 26, 2024 10-Q ↗	Q1 FY2024 Apr 26, 2024 10-Q ↗	Q4 FY2023 Apr 28, 2023 10-K ↗
Revenue per Share (USD)	—	$3.12	—	—	$2.72	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.71	$-0.47	—	$-0.68	$-0.04	—	—	—	—	—	—	—
Book Value per Share (USD)	$12.86	—	—	—	$14.08	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$4.44	—	—	—	$14.08	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	—	252.81M	—	—	252.81M	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q4 FY2026 Apr 24, 2026 10-K ↗	Q3 FY2026 Jan 23, 2026 10-Q ↗	Q1 FY2026 Jan 23, 2026 10-Q ↗	Q4 FY2025 Apr 25, 2025 10-K ↗	Q3 FY2025 Oct 24, 2025 10-Q ↗	Q2 FY2025 Jul 25, 2025 10-Q ↗	Q1 FY2025 Apr 25, 2025 10-Q ↗	Q4 FY2024 Apr 26, 2024 10-K ↗	Q3 FY2024 Oct 25, 2024 10-Q ↗	Q2 FY2024 Jul 26, 2024 10-Q ↗	Q1 FY2024 Apr 26, 2024 10-Q ↗	Q4 FY2023 Apr 28, 2023 10-K ↗
Working Capital (USD)	$646.00M	—	$412.00M	$229.00M	—	—	$229.00M	—	—	—	—	—
Total Equity (USD)	$3.61B	—	$3.46B	$3.33B	$3.56B	$3.54B	$3.48B	$3.45B	$3.46B	$3.48B	$3.45B	$3.40B

📋 What is driving earnings? 4 metrics

Metric	Q4 FY2026 Apr 24, 2026 10-K ↗	Q3 FY2026 Jan 23, 2026 10-Q ↗	Q1 FY2026 Jan 23, 2026 10-Q ↗	Q4 FY2025 Apr 25, 2025 10-K ↗	Q3 FY2025 Oct 24, 2025 10-Q ↗	Q2 FY2025 Jul 25, 2025 10-Q ↗	Q1 FY2025 Apr 25, 2025 10-Q ↗	Q4 FY2024 Apr 26, 2024 10-K ↗	Q3 FY2024 Oct 25, 2024 10-Q ↗	Q2 FY2024 Jul 26, 2024 10-Q ↗	Q1 FY2024 Apr 26, 2024 10-Q ↗	Q4 FY2023 Apr 28, 2023 10-K ↗
Sales/Revenue/Turnover (USD)	$837.00M	$790.00M	—	$724.00M	$687.00M	—	—	—	—	—	—	—
Depreciation Expense (USD)	$39.00M	—	—	$38.00M	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-185.00M	$-119.00M	—	$-172.00M	$-10.00M	—	—	—	$-19.00M	—	—	—
Operating Cash Flow (USD)	$-170.00M	—	—	$83.00M	—	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 12 quarters

MiniMed Group, Inc.

Analytical Summary

12-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare MMED with peers